1.5 Million U.S. Adults Have Vision-Affecting Glaucoma
By Lori Solomon HealthDay Reporter
FRIDAY, Oct. 18, 2024 -- An estimated 2.56 percent of U.S. adults ages 40 years and older have glaucoma, according to a study published online Oct. 17 in JAMA Ophthalmology.
Joshua R. Ehrlich, M.D., from University of Michigan, Ann Arbor, and colleagues used the Centers for Disease Control and Prevention Vision and Eye Health Surveillance System to estimate glaucoma prevalence among U.S. states and counties in 2022.
The researchers found that an estimated 4.22 million people were living with glaucoma in the United States in 2022. The prevalence was 1.62 percent for adults overall and 2.56 percent for those ages 40 years and older. Vision-affecting glaucoma impacted an estimated 1.49 million people (0.57 percent of adults overall and 0.91 percent among people ages 40 years and older). Geographic prevalence varied from 1.11 percent of adults in Utah to 1.95 percent in Mississippi. Prevalence was higher among Black adults versus White (3.15 and 1.42 percent, respectively). For Hispanic adults, the prevalence was 1.56 percent.
“These estimates may help provide information for the development and prioritization of public health strategies and interventions, the monitoring of epidemiologic trends, and evaluation of programs tailored for communities and populations at highest risk of glaucoma,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis
TUESDAY, Sept. 2, 2025 -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduction in the risk for developing uveitis, according to a study published...
Omega-3 PUFA Intake May Be Protective Against Myopia
MONDAY, Aug. 25, 2025 -- Omega-3 polyunsaturated fatty acid (ω-3 PUFA) intake may be protective against myopia in children, according to a study published online Aug. 19 in...
Corticosteroids Not Superior to Placebo for Add-On Treatment of Bacterial Keratitis
MONDAY, July 28, 2025 -- For the treatment of bacterial keratitis, adjunctive corticosteroids are not superior to placebo and adjunctive corneal cross-linking (CXL) is associated...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.